Your browser doesn't support javascript.
loading
Extracellular vesicles engineered with valency-controlled DNA nanostructures deliver CRISPR/Cas9 system for gene therapy.
Zhuang, Jialang; Tan, Jizhou; Wu, Chenglin; Zhang, Jie; Liu, Ting; Fan, Chunhai; Li, Jiaping; Zhang, Yuanqing.
Afiliação
  • Zhuang J; Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, Guangdong 510006, China.
  • Tan J; Department of Interventional Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, P. R. China.
  • Wu C; Department of Interventional Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, P. R. China.
  • Zhang J; Organ Transplantation Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, P. R. China.
  • Liu T; Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, Guangdong 510006, China.
  • Fan C; Department of Interventional Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, P. R. China.
  • Li J; School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Dongchuan Rd 800, Shanghai 200240, P. R. China.
  • Zhang Y; Department of Interventional Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, P. R. China.
Nucleic Acids Res ; 48(16): 8870-8882, 2020 09 18.
Article em En | MEDLINE | ID: mdl-32810272
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Genética / Nanoestruturas / Aptâmeros de Nucleotídeos / Sistemas CRISPR-Cas / Vesículas Extracelulares / Neoplasias Hepáticas Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Genética / Nanoestruturas / Aptâmeros de Nucleotídeos / Sistemas CRISPR-Cas / Vesículas Extracelulares / Neoplasias Hepáticas Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China